Home > Financial Ratios > SOTAC PHARMACEUTICALS

SOTAC PHARMACEUTICALS
EBIT Growth

    Back to All Ratios
COMMUNITY POLL
for SOTAC PHARMACEUTICALS
Please provide your vote to see the results

SOTAC PHARMACEUTICALS Last 5 Year EBIT Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EBIT Growth(%) 140.28-4.4613.37610.65-249.43

What is the latest EBIT Growth ratio of SOTAC PHARMACEUTICALS ?

The latest EBIT Growth ratio of SOTAC PHARMACEUTICALS is 140.28 based on Mar2025 Consolidated results.
Year EBIT Growth
Mar2025140.28
Mar2024-4.46
Mar202313.37
Mar2022610.65
Mar2021-249.43

How is EBIT Growth of SOTAC PHARMACEUTICALS Trending?

Years EBIT Growth % Change
Mar2025 140.28
Positive
Mar2024 -4.46
Negative
Mar2023 13.37
-97.81
Mar2022 610.65
Positive
Mar2021 -249.43 -

Other Financial Ratios of SOTAC PHARMACEUTICALS


Compare EBIT Growth ratio of peers of SOTAC PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SOTAC PHARMACEUTICALS ₹111.0 Cr -14.5% -23% -26.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹386,905.0 Cr -5.2% -7.6% -8.6% Stock Analytics
DIVIS LABORATORIES ₹159,357.0 Cr -5.6% -7.3% 1.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹134,788.0 Cr -0.6% 4.8% 25% Stock Analytics
CIPLA ₹110,628.0 Cr -4.5% -9.7% -4.6% Stock Analytics
DR REDDYS LABORATORIES ₹96,441.5 Cr -2.6% -9.7% -10.5% Stock Analytics


SOTAC PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
SOTAC PHARMACEUTICALS

-14.5%

-23%

-26.1%

SENSEX

-2.1%

-3%

6.8%


You may also like the below Video Courses